ReShape Lifesciences

HIND

NASDAQHealth Care

Income Statement

Total Revenue$5.8M

Gross Profit$3.66M

Operating Income$-6.25M

EBITDA$-6.01M

EBIT$-6.03M

Pre-tax Income$-13.48M

Net Income$-6.1M

Cash Equivalent$1.14M

Total Debt$1.07M

Book Value$1.17M

Book Value Per Share252.12

Return on Equity (ROE)-170.90%

Return on Assets (ROA)-148.76%

Return on Invested Capital (ROI)-170.90%

Net Profit Margin-89.06%

Current Ratio0.92

Quick Ratio0.37

Long-Term Debt / Equity0.09